Landscapes / Companies
Ascendis Pharma Growth Disorders A/S not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 approved
Drugs
2
in active trials
Trials
2 active
3 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Ascendis Pharma A/S |
Approved | Jan 2039Phase 2/3 trial completes | ||
| Next date | Jan 2039 · Phase 2/3 trial completes | ||||
| Also tested for | Achondroplasia | ||||
| Open drug page | |||||
Recombinant human growth hormone |
Ascendis Pharma Endocrinology Division A/S |
Approved | — | ||
| Also tested for | Achondroplasia | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021